Zhengxuan Jiang

Dr. Zhengxuan Jiang


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 March 2023 in Autoimmunity Reviews
Verified
Journal Article
Closed access
FCFan Cao
Fan Cao
YHYi-Sheng He
Yi-Sheng He
YWYan Wang
Yan Wang
CZChen-Kai Zha
Chen-Kai Zha
JLJia-Min Lu
Jia-Min Lu
HPHai-Feng Pan
Hai-Feng Pan

17 May 2023 in Autoimmunity Reviews
Verified
Journal Article
Closed access
FCFan Cao
Fan Cao
YLYu-Chen Liu
Yu-Chen Liu
QNQin-Yu Ni
Qin-Yu Ni
YCYue Chen
Yue Chen
CWCheng-Huan Wan
Cheng-Huan Wan
HPHai-Feng Pan
Hai-Feng Pan

4 September 2023 in Annals of the Rheumatic Diseases
Verified
Journal Article
Closed access
FCFan Cao
Fan Cao
DLDa-Peng Li
Da-Peng Li
GWGuo-Cui Wu
Guo-Cui Wu
YHYi-Sheng He
Yi-Sheng He
YLYu-Chen Liu
Yu-Chen Liu
HPHai-Feng Pan
Hai-Feng Pan
To provide an overview and in-depth analysis of temporal trends in prevalence of musculoskeletal (MSK) disorders in women of childbearing age (WCBA) at global, regional and national levels over the last 30 years, with a special focus on their associations with age, period and birth cohort. Estimates and 95% uncertainty intervals (UIs) for MSK disorders prevalence in WCBA were extracted from the Global Burden of Diseases, Injuries and Risk Factors Study 2019. An age-period-cohort model was adopted to estimate the overall annual percentage change of prevalence (net drift, % per year), annual percentage change of prevalence within each age group (local drift, % per year), fitted longitudinal age-specific rates adjusted for period deviations (age effects) and period/cohort relative risks (period/cohort effects) from 1990 to 2019. In 2019, the global number of MSK disorders prevalence in WCBA was 354.57 million (95% UI: 322.64 to 387.68). Fifty countries had at least one million prevalence, with India, China, the USA, Indonesia and Brazil being the highest accounting for 51.03% of global prevalence. From 1990 to 2019, a global net drift of MSK disorders prevalence in WCBA was -0.06% (95% CI: -0.07% to -0.05%) per year, ranging from -0.09% (95% CI: -0.10% to -0.07%) in low-middle sociodemographic index (SDI) region to 0.10% (95% CI: 0.08% to 0.12%) in high-middle SDI region, with 138 countries presenting increasing trends, 24 presenting decreasing trends and 42 presenting relatively flat trends. As reflected by local drift, higher SDI regions had more age groups showing rising prevalence whereas lower SDI regions had more declining prevalence. Globally, an increasing occurrence of MSK disorders prevalence in WCBA beyond adolescent and towards the adult stage has been prominent. Age effects illustrated similar patterns across different SDI regions, with risk increasing with age. High SDI region showed generally lower period risks over time, whereas others showed more unfavourable period risks. High, high-middle and middle SDI regions presented unfavourable prevalence deteriorations, whereas others presented favourable prevalence improvements in successively birth cohorts. Although a favourable overall temporal trend (net drift) of MSK disorders prevalence in WCBA was observed over the last 30 years globally, there were 138 countries showing unfavourable rising trends, coupled with deteriorations in period/cohort risks in many countries, collectively raising concerns about timely realisation of the Targets of Sustainable Development Goal. Improvements in the MSK disorders-related prevention, management and treatment programmes in WCBA could decline the relative risk for successively younger birth cohorts and for all age groups over period progressing.

1 February 2021 in Environmental Research
Verified
Journal Article
Closed access
CHCheng-Yang Hu
Cheng-Yang Hu
XYXiao-Jing Yang
Xiao-Jing Yang
SGSi-Yu Gui
Si-Yu Gui
KDKun Ding
Kun Ding
KHKai Huang
Kai Huang
XZxiujun zhang
xiujun zhang

3 September 2022 in Redox Biology
Verified
Journal Article
Open access
KLKou Liu
Kou Liu
XGXiang Gao
Xiang Gao
CHChengyang Hu
Chengyang Hu
YGYanchao Gui
Yanchao Gui
SGSiyu Gui
Siyu Gui
ZJZhengxuan Jiang
Zhengxuan Jiang
Oxidative stress and the resultant hyperpermeability play a vital role in the pathogenesis of diabetic retinopathy (DR). Poldip2 has been implicated in H2O2 production, but the effects of capsaicin on poldip2 have not been reported. Diabetic Sprague-Dawley (SD) rats induced with STZ were treated with capsaicin or AAV9-poldip2-shRNA, and human retinal microvascular endothelial cells (HRMECs) were treated with capsaicin or poldip2 siRNA. Current data indicated that the expression of PPARγ, poldip2, Nox4, VCAM-1, HIF-1α, and VEGF increased in rat retinas with DR and in HRMECs treated with high glucose. The production of ROS or H2O2 in the tissues, serum, and cells increased, and the paracellular permeability of cultured HRMECs with high glucose significantly increased. In addition, overt hyperpermeability of retinal microvessels and increased retinal neovascularization in diabetic rats were observed. However, capsaicin treatment inhibited these increases and suppressed the expression of PPARγ by enhancing its phosphorylation and ubiquitination in the retinas of DR rats. Poldip2 knockdown in HRMECs or its silencing in the retina of DR rats concomitantly led to reduced levels of Nox4, VCAM-1, HIF-1α, VEGF, ROS, and H2O2, and the paracellular permeability of HRMECs or the hyperpermeability of retinal microvessels in diabetic rat retinas decreased. Similarly, after PPARγ knockdown in HRMECs, poldip2, Nox4, HIF-1α, VEGF, ROS, and H2O2 decreased, and the monolayer paracellular permeability was reduced accordingly. Capsaicin may ameliorate diabetic retinopathy by activating TRPV1 and suppressing the PPARγ-poldip2-Nox4 pathway.

1 August 2020 in Chemosphere
Verified
Journal Article
Closed access
CHCheng-Yang Hu
Cheng-Yang Hu
KHKai Huang
Kai Huang
YFYuan Fang
Yuan Fang
XYXiao-Jing Yang
Xiao-Jing Yang
KDKun Ding
Kun Ding
XZxiujun zhang
xiujun zhang